The use of reperfusion therapy in transition countries without fully applicable pharmacoinvasive strategy

The use of reperfusion therapy in transition countries without fully applicable pharmacoinvasive strategy

Background/Aim. The pharmacoinvasive (PI) therapy is a recommended strategy in patients (pts) with ST elevation myocardial infarction (STEMI) unable to undergo timely primary percutaneous coronary intervention (p-PCI). The aim of the study was to find out the cohorts of pts who are not treated by an...

Full description

Bibliographic Details
Main Authors: Krljanac Gordana, Ašanin Milika, Mickovski-Katalina Nataša, Milanović Slađan D., Bjekić Jovana, Savić Lidija, Mitrović Predrag, Đurović Marina, Vasiljević Zorana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2022-01-01
Series:Vojnosanitetski Pregled
Subjects:
drug therapy
st elevation myocardial infarction
myocardial reperfusion
risk factors
serbia
treatment outcome
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502000090K.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502000090K.pdf

Similar Items